Publication of a Prospectus

Royal Bank of Canada
08 August 2023
 

 

 

 


Publication of Prospectus

 

Not for release, publication or distribution, directly or indirectly, in or into the United States.

 

Royal Bank of Canada today issued EUR20,000,000 1.034 per cent. Senior Notes due January 25, 2034 (to be consolidated and form a single series with EUR450,000,000 1.034 per cent. Senior Notes due January 25, 2034 issued on January 25, 2022 (Tranche 1), EUR40,000,000 1.034 per cent. Senior Notes due January 25, 2034 issued on October 20, 2022 (Tranche 2)), EUR28,000,000 1.034 per cent. Senior Notes due January 25, 2034 issued on February 13, 2023 (Tranche 3), and EUR82,000,000 1.034 per cent. Senior Notes due January 25, 2034 issued on June 7, 2023 (Tranche 4), Series 64148) (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme").

 

The following document constitutes the final terms dated August 4, 2023 (the "Final Terms") relating to the admission to trading of the Notes for purpose of Article 8 of Regulation (EU) 2017/1129 and as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (EUWA)  and must be read in conjunction with the Terms and Conditions contained in the Prospectus dated July 23, 2021 which are incorporated by reference in the Prospectus dated July 14, 2023 relating to the Programme (together, the "Prospectus").  Full information on Royal Bank of Canada and the offer of the Notes is only available on the basis of the combination of the Final Terms and the Prospectus.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus and the Final Terms, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed.  Prior to relying on the information contained in the Final Terms you must ascertain from the Prospectus, as supplemented by these Final Terms, whether or not you are part of the intended addressees of the information contained therein.

 

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the US and are subject to US tax law requirements.  Subject to certain exceptions, the Notes may not be offered, sold or delivered in or into the United States or to or for the account or benefit of a "US person" (as defined in Regulation S under the Securities Act).  No public offering of the Notes is being made in the United States.  This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above requirement.

 

UK MiFIR professionals / ECPs-only / No PRIIPs or UK PRIIPs KID - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels).  No PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or the UK.

 

To view the full document, please paste the following URLs into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/7030I_1-2023-8-8.pdf

 

 

 

For further information, please contact

Paul Burd

Senior Counsel

Royal Bank of Canada

Telephone Number:  (437) 925-9253

Fax Number:  (416) 955-2032

Email:  paul.burd@rbc.com

 

 

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings